JOURNEY MEDICAL CORP (DERM)

Company Profile

Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company is headquartered in Scottsdale, Arizona and currently employs 80 full-time employees. The company went IPO on 2021-11-12. The firm is focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its portfolio includes over eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Its marketed products that have been approved by the United States Food and Drug Administration (FDA) for sale include Qbrexza, Accutane, Targadox, Ximino, and Exelderm Cream and Solution. The firm's product Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, which is an oral isotretinoin drug for the treatment of severe recalcitrant severe acne; Targadox, which is an oral doxycycline drug for adjunctive therapy for acne; Ximino, which is an oral minocycline drug for the treatment of moderate to severe acne, and Exelderm Cream and Solution is an antifungal intended for topical use.

Company Info

JOURNEY MEDICAL CORP

9237 E Via De Ventura Blvd., Suite 105, Suite 105

Scottsdale ARIZONA 94025

P: 14804346670

CEO: Thomas G. Wiggans

Employees: 80

Website: https://journeymedicalcorp.com/